Jaroslav Jelı́nek

11.9k total citations · 2 hit papers
159 papers, 8.3k citations indexed

About

Jaroslav Jelı́nek is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Jaroslav Jelı́nek has authored 159 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Molecular Biology, 54 papers in Hematology and 27 papers in Genetics. Recurrent topics in Jaroslav Jelı́nek's work include Epigenetics and DNA Methylation (92 papers), Acute Myeloid Leukemia Research (47 papers) and Cancer-related gene regulation (39 papers). Jaroslav Jelı́nek is often cited by papers focused on Epigenetics and DNA Methylation (92 papers), Acute Myeloid Leukemia Research (47 papers) and Cancer-related gene regulation (39 papers). Jaroslav Jelı́nek collaborates with scholars based in United States, Czechia and Japan. Jaroslav Jelı́nek's co-authors include Jean‐Pierre J. Issa, Lanlan Shen, Marcos R. Estecio, Woonbok Chung, Hagop M. Kantarjian, Josef T. Prchal, Shoudan Liang, Yue Lu, Vazganush Gharibyan and Taichun Qin and has published in prestigious journals such as Nucleic Acids Research, Nature Medicine and Nature Communications.

In The Last Decade

Jaroslav Jelı́nek

153 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dnmt3a is essential for hematopoietic stem cell differentiation

2011 791 citations Jaroslav Jelı́nek, Aparna Vasanthakumar et al. profile →
Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma

2014 354 citations Tomomitsu Tahara, Eiichiro Yamamoto et al. Cancer Research profile →

Peers

Jaroslav Jelı́nek

HEMAT

GENET

ONCOL

Sakari Knuutila Finland

Kevin Shannon United States

Claus Nerlov United Kingdom

Michael Lübbert Germany

Matthew L. Sherman United States

Atsushi Hirao Japan

Vicente Andrés Spain

Donald C. Foster United States

Wei Tong United States

Neil V. Morgan United Kingdom

Sakari Knuutila Finland

Jaroslav Jelı́nek

3.8k ×0.6

1.4k ×0.6

HEMAT

1.4k ×1.1

1.7k ×1.3

GENET

1.7k ×1.6

ONCOL

Citations per year, relative to Jaroslav Jelı́nek Jaroslav Jelı́nek (= 1×) peers Sakari Knuutila

Countries citing papers authored by Jaroslav Jelı́nek

Since Specialization

Citations

This map shows the geographic impact of Jaroslav Jelı́nek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaroslav Jelı́nek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaroslav Jelı́nek more than expected).

Fields of papers citing papers by Jaroslav Jelı́nek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaroslav Jelı́nek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaroslav Jelı́nek. The network helps show where Jaroslav Jelı́nek may publish in the future.

Co-authorship network of co-authors of Jaroslav Jelı́nek

This figure shows the co-authorship network connecting the top 25 collaborators of Jaroslav Jelı́nek. A scholar is included among the top collaborators of Jaroslav Jelı́nek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaroslav Jelı́nek. Jaroslav Jelı́nek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jelı́nek, Jaroslav, Hai Chen, Yan Zhang, et al.. (2024). Genome-wide screening and functional validation of methylation barriers near promoters. Nucleic Acids Research. 52(9). 4857–4871. 2 indexed citations

Chang, Wen‐Chi, Jayashri Ghosh, Harry S. Cooper, et al.. (2023). Folic Acid Supplementation Promotes Hypomethylation in Both the Inflamed Colonic Mucosa and Colitis-Associated Dysplasia. Cancers. 15(11). 2949–2949. 2 indexed citations

Kim, Jee Yeon, Jaroslav Jelı́nek, Young Ho Lee, et al.. (2023). Hypomethylation in MTNR1B: a novel epigenetic marker for atherosclerosis profiling using stenosis radiophenotype and blood inflammatory cells. Clinical Epigenetics. 15(1). 11–11. 6 indexed citations

Good, Charly R., Shoghag Panjarian, Andrew D. Kelly, et al.. (2018). TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer. Cancer Research. 78(15). 4126–4137. 108 indexed citations

Ven, Leo T.M. van der, Jaroslav Jelı́nek, Hennie M. Hodemaekers, et al.. (2017). An Adverse Outcome Pathway Analysis Employing DNA Methylation Effects in Arsenic-Exposed Zebrafish Embryos Supports a Role of Epigenetic Events in Arsenic-Induced Chronic Disease. Rivm Repository (Netherlands National Institute for Public Health and the Environment). 3(4). 312–324. 3 indexed citations

Sato, Takahiro, Matteo Cesaroni, Woonbok Chung, et al.. (2016). Transcriptional Selectivity of Epigenetic Therapy in Cancer. Cancer Research. 77(2). 470–481. 49 indexed citations

Malouf, Gabriel G., Xiaoping Su, Jianping Zhang, et al.. (2016). DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas. Clinical Cancer Research. 22(24). 6236–6246. 39 indexed citations

Yamazaki, Jumpei, Jaroslav Jelı́nek, Yue Lu, et al.. (2015). TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor–Binding Sites in Chronic Myelomonocytic Leukemia. Cancer Research. 75(14). 2833–2843. 67 indexed citations

Tahara, Tomomitsu, Eiichiro Yamamoto, Hiromu Suzuki, et al.. (2014). Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma. Cancer Research. 74(5). 1311–1318. 354 indexed citations breakdown →

10.

Tahara, Tomomitsu, Shinji Maegawa, Woonbok Chung, et al.. (2013). Examination of Whole Blood DNA Methylation as a Potential Risk Marker for Gastric Cancer. Cancer Prevention Research. 6(10). 1093–1100. 31 indexed citations

11.

Raynal, Noël J.‐M., Jiali Si, Rodolphe F. Taby, et al.. (2012). DNA Methylation Does Not Stably Lock Gene Expression but Instead Serves as a Molecular Mark for Gene Silencing Memory. Cancer Research. 72(5). 1170–1181. 106 indexed citations

12.

Chung, Woonbok, Jolanta Bondaruk, Jaroslav Jelı́nek, et al.. (2011). Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments. Cancer Epidemiology Biomarkers & Prevention. 20(7). 1483–1491. 127 indexed citations

13.

Pathiraja, Thushangi N., Priya B. Shetty, Jaroslav Jelı́nek, et al.. (2011). Progesterone Receptor Isoform-Specific Promoter Methylation: Association of PRA Promoter Methylation with Worse Outcome in Breast Cancer Patients. Clinical Cancer Research. 17(12). 4177–4186. 42 indexed citations

14.

Si, Jiali, Yanis Boumber, Jingmin Shu, et al.. (2010). Chromatin Remodeling Is Required for Gene Reactivation after Decitabine-Mediated DNA Hypomethylation. Cancer Research. 70(17). 6968–6977. 58 indexed citations

15.

Kwabi‐Addo, Bernard, Songping Wang, Woonbok Chung, et al.. (2010). Identification of Differentially Methylated Genes in Normal Prostate Tissues from African American and Caucasian Men. Clinical Cancer Research. 16(14). 3539–3547. 98 indexed citations

16.

Konishi, Kazuo, Lanlan Shen, Jaroslav Jelı́nek, et al.. (2009). Concordant DNA Methylation in Synchronous Colorectal Carcinomas. Cancer Prevention Research. 2(9). 814–822. 37 indexed citations

17.

Wang, Jie, Manisha Bhutani, Ashutosh Pathak, et al.. (2007). ΔDNMT3B Variants Regulate DNA Methylation in a Promoter-Specific Manner. Cancer Research. 67(22). 10647–10652. 47 indexed citations

18.

Qin, Taichun, Jaroslav Jelı́nek, & Jean‐Pierre J. Issa. (2007). Mechanisms of naturally occurring resistance to 5-Aza-2'-deoxycytidine in human cancer cell lines. Molecular Cancer Therapeutics. 6. 2 indexed citations

19.

Jelı́nek, Jaroslav, Vazganush Gharibyan, Rong He, et al.. (2007). DNA methylation of HOX genes in leukemia and myeloproliferative disorders. Cancer Research. 67. 235–235. 2 indexed citations

20.

Shu, Jingmin, Jaroslav Jelı́nek, Hao Chang, et al.. (2006). Silencing of Bidirectional Promoters by DNA Methylation in Tumorigenesis. Cancer Research. 66(10). 5077–5084. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact